Designing the drugs of tomorrow demands a predict-first approach
Running modern drug discovery programs is full of challenges. For more than 30 years, Schrödinger has enabled biotech and pharmaceutical teams worldwide with a computational platform for molecular design and discovery.
of the Top 20 Pharma companies use Schrödinger
Companies license Schrödinger software worldwide
Morphic Therapeutic leverages digital chemistry strategy to design a novel small molecule inhibitor of α4β7 integrin
In this case study, we describe how Morphic Therapeutic, experts in all things integrin, partnered with Schrödinger’s drug discovery team to design an orally bioavailable drug selectively targeting α4β7 integrin to treat inflammatory bowel disease.read the case study
Software and services to meet your organizational needs
Deploy digital drug discovery workflows using a comprehensive and user-friendly platform for molecular modeling, design, and collaboration.
Leverage Schrödinger’s computational expertise and technology at scale to advance your projects through key stages in the drug discovery process.
Support & Training
Access expert support, educational materials, and training resources designed for both novice and experienced users.